References

• 1. Pernar CH, Ebot EM, Wilson KM, Mucci LA. The epidemiology of prostate cancer. Cold Spring Harb Perspect Med 2018; 8(12): a030361. google scholar
• 2. Kulasegaran T, Oliveira N. Metastatic castration-resistant prostate 19. cancer: Advances in treatment and symptom management. Curr Treat Options Oncol 2024; 25(7): 914-31. google scholar
• 3. Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR. Management of complications of prostate cancer 20. treatment. CA Cancer J Clin 2008; 58(4): 196-213. google scholar
• 4. Fraser M, Berlin A, Bristow RG, van der Kwast T. Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in 21. prostate cancer. Urol Oncol-Semin Ori 2015; 33(2): 85-94. google scholar
• 5. Matsumoto M, Miki T, Shibasaki T, Kawaguchi M, Shinozaki H, Nio J, et al. Noc2 is essential in normal regulation of exocytosis in endocrine and exocrine cells. Proc Natl Acad Sci U S A 2004; 101(22): 8313-8. 22. google scholar
• 6. Guo YP. Understanding prostate cancer genetic susceptibility and chromatin regulation: University of Southern California, Doctoral Thesis. 2019. google scholar
• 7. Wu Q, Zhou Y, Chen L, Shi J, Wang CY, Miao L, et al. Benign 23. prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2. J Endocrinol 2007; 195(1): 89-94. google scholar
• 8. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. 24. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979; 17(1):16-23. google scholar
• Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 1978; 21(3): 274-81. google scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15(12): 550. google scholar
• 11. Alhamdoosh M, Law CW, Tian L, Sheridan JM, Ng M, Ritchie ME. Easy and efficient ensemble gene set testing with EGSEA. 27. F1000Res 2017; 6: 2010. google scholar
• 12. Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 2017; 45(W1): W98-W102. google scholar
• 13. Kypta RM, Waxman J. Wnt/beta-catenin signalling in prostate cancer. Nat Rev Urol 2012; 9(8): 418-28. google scholar
• 14. Wang C, Chen Q, Xu H. Wnt/beta-catenin signal transduction pathway in prostate cancer and associated drug resistance. Discov Oncol 2021; 12(1): 40. google scholar
• 15. Shibata A, Jeggo PA. ATM’s role in the repair of dna double-strand breaks. Genes (Basel) 2021; 12(9): 1370. google scholar
• 16. Castro E, Eeles R. The role of BRCA1 and BRCA2 in prostate cancer. Asian J Androl 2012; 14(3): 409-14. google scholar
• 17. Fenton SE, Saleiro D, Platanias LC. Type I and II interferons in the anti-tumor immune response. Cancers (Basel) 2021; 13(5): 1037. google scholar
• 18. Hastie C. Interferon gamma, a possible therapeutic approach for late-stage prostate cancer? Anticancer Res 2008; 28(5B): 2843-9. google scholar
• 19. Hagiwara M, Fushimi A, Bhattacharya A, Yamashita N, Morimoto Y, Oya M, et al. MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer. Oncoimmunology 2022; 11(1): 2029298. google scholar
• 20. Guo W, Liu H, Yan Y, Wu D, Yao H, Lin K, et al. Targeting the TGF-beta signaling pathway: an updated patent review (2021-present). Expert Opin Ther Pat 2024; 34(3): 99-126. google scholar
• 21. Eisenhofer G, Huynh TT, Elkahloun A, Morris JC, Bratslavsky G, Linehan WM, et al. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma. Am J Physiol Endocrinol Metab 2008; 295(5): E1223-33. google scholar
• 22. Smith JS, Tachibana I, Allen C, Chiappa SA, Lee HK, McIver B, et al. Cloning of a human ortholog (RPH3AL) of (RNO)Rph3al from a candidate 17p13.3 medulloblastoma tumor suppressor locus. Genomics 1999; 59(1): 97-101. google scholar
• 23. Lv L, Zhang D, Hua P, Yang S. The glial-specific hypermethylated 3 untranslated region of histone deacetylase 1 may modulates several signal pathways in Alzheimer’s disease. Life Sciences 2021; 265: 118760. google scholar
• 24. Martı'nez Arroyo O. Insights into the role of the RAB3A-RAB27A system on the development of kidney injury associated with type II diabetes mellitus. University of Valencia, Doctoral Thesis. 2024. google scholar
• 25. Chipidza FE, Alshalalfa M, Mahal BA, Karnes RJ, Liu Y, Davicioni E, et al. Development and validation of a novel TP53 mutation signature that predicts risk of metastasis in primary prostate cancer. Clin Genitourin Cancer 2021; 19(3): 246-54.e5. google scholar
• 26. Putcha BD, Jia X, Katkoori VR, Salih C, Shanmugam C, Jadhav T, et al. Clinical implications of Rabphillin-3A-Like gene alterations in breast cancer. PLoS One 2015; 10(6): e0129216. google scholar
• 27. Chen JS, Kuo YB, Chou YP, Chan CC, Fan CW, Chen KT, et al. Detection of autoantibodies against Rabphilin-3A-like protein as a potential biomarker in patient’s sera of colorectal cancer. Clin Chim Acta 2011; 412(15-16): 1417-22. google scholar
• 28. Shibasaki T, Seino S. Physical and functional interaction of noc2/ rab3 in exocytosis. Methods Enzymol 2005; 403: 408-19. google scholar

Citations